Recombinant human interferon α2a suppository

Recombinant human interferon alpha;2a has a broad-spectrum antiviral effect. Its antiviral mechanism is mainly achieved by binding interferon to interferon receptors on the surface of target cells, inducing multiple antiviral proteins such as 2-5(A) synthetase, protein kinase PKR, MX protein in target cells, preventing the synthesis of viral protein, inhibiting the replication and transcription of viral nucleic acid. Interferon also has multiple immunomodulatory effects, which can increase macrophage activity and enhance the specific cytotoxicity of lymphocytes to target cells, promote and maintain the body's immune surveillance, immune protection and immune self-stabilization functions. Toxicological studies 1. Acute toxicity test: All mice survived after intravenous or intramuscular injection of the maximum dose, without death, and no LD50 was established. 2. Long-term toxicity test: Rats were given the drug continuously for months, and all animals survived without abnormal reactions.

Recombinant human interferon α2a

This product is a white or yellow suppository with uniform, smooth shape and hard texture.

Used to treat chronic cervicitis, cervical erosion, vaginitis caused by vaginal viral infection, and to prevent cervical cancer.

1. Place the suppository in the posterior fornix of the vagina; 2. Take one tablet at a time, once every other day, before going to bed. 3. Six to ten times is a course of treatment or follow the doctor's advice.

A very small number of patients may experience mild back and abdominal pain after the first use of the medication, occasionally transient low-grade fever, and discomfort in the vulva and vagina, which may disappear on their own and do not affect the treatment.

It is forbidden to use for children and pregnant women.

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: Pregnant women are prohibited from using this product, but it is normal for lactating women to use it. Precautions for the elderly: This product can be used.

Concurrent use with other drugs has no effect on drug efficacy.

Store and transport at 2-8℃ away from light.

60,000 IU/piece

18 months

Wuhan Weiao Pharmacauti Cal Co., Ltd.

• Founded in:

  1996-10-30

• Address:

  Wuhan University Science and Technology Park, Jiangxia Avenue, East Lake New Technology Development Zone, Wuhan

• Tax NO.:

  91420100616432784K

• Registered Funds:

  30 million yuan

• Website:

  Log in to view

• Email:

  Log in to view